SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-017012
Filing Date
2019-08-30
Accepted
2019-08-30 15:49:18
Documents
6
Period of Report
2019-08-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k083019a_alteritytherap.htm 6-K 14117
2 APPENDIX 4E & ANNUAL REPORT 2019 f6k083019aex99-1_alterity.htm EX-99.1 1442019
3 GRAPHIC ex99-1_001.jpg GRAPHIC 270770
4 GRAPHIC ex99-1_002.jpg GRAPHIC 9462
5 GRAPHIC ex99-1_003.jpg GRAPHIC 6216
6 GRAPHIC ex99-1_004.jpg GRAPHIC 14517
  Complete submission text file 0001213900-19-017012.txt   1872296
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 191069495
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences